Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.
Former Eastman Kodak Scientist and Engineers Develop Liquid Germ Killer Hy-IQ® to Revolutionize the way Deadly Bacteria and Virus are Eradicated
The Aphex BioCleanse solution (a liquid)...
Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on 180 Million Shares!
We've played many sector manias in the past (operative word 'play') such as solar, stem cells, restaurants, blockchain, marijuana, and patent monetization to name...
Draganfly (DFLYF) Closes $15 Million Reg A Offering.
Draganfly Enters Agreement with Applied Research and Innovations Services at Southern Alberta..
The Company announces that it has completed the final closing of its Regulation...
Whitepaper: Effects of Magnetic Fields on Biological Systems
CLICK TO VIEW
EMULATE THERAPEUTICS
Our Favorite Incubator, Incubates! Telehealth in its Future?
True Nature|Mitesco has found an excellent first Company to incubate and help grow, called MyCare.The founders of the Minute Clinic are teaming up again...
Draganfly (DFLYF) Holds ‘Pole Position’ in Race for Drone Supremacy After Chinese Barred from...
STREETWISE REPORTS - March 3, 2020
The company establishes a toehold with U.S. government, homeland security and military contractors, and readies drones to screen for...
Augmentative Wearable Device, Hapbee, Receives Amazing Reviews by Testers.
Originally posted on MartechSeries.
The innovative augmentative wearable device, Hapbee, has been giving testers a reason to be happy. With the ability to allow users...
VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...
Internet Stock Review
Blast from the past scores big!
We added VirnetX (VHC) to the Watch List (Patent Stock Review, since shuttered) back in 2010....
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.
Citius Pharma (CTXR) Inches Closer to the Next Phase III Data Announcement.
Citius Pharma Presenting at...
Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
PHASE III PROGRESS
October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019 - Data Analysis Back, Results Positive.February...















